Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

Shares of Synthomer plc (LON:SYNT - Get Rating) have been assigned a consensus rating of "Hold" from the six research firms that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and two have given a buy recommendation to the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is GBX 445.50 ($5.38).

A number of analysts recently weighed in on SYNT shares. Berenberg Bank decreased their price objective on Synthomer from GBX 350 ($4.23) to GBX 275 ($3.32) and set a "hold" rating for the company in a report on Thursday, August 4th. Barclays reiterated an "equal weight" rating and set a GBX 323 ($3.90) price target on shares of Synthomer in a report on Wednesday, August 3rd. Finally, JPMorgan Chase & Co. decreased their price target on Synthomer from GBX 430 ($5.20) to GBX 350 ($4.23) and set a "neutral" rating for the company in a report on Wednesday, August 3rd.Insider Activity at Synthomer

In other news, insider Roberto Gualdoni bought 20,000 shares of the company's stock in a transaction on Tuesday, August 2nd. The shares were purchased at an average price of GBX 214 ($2.59) per share, with a total value of £42,800 ($51,715.80). In other news, insider Roberto Gualdoni bought 20,000 shares of the company's stock in a transaction on Tuesday, August 2nd. The shares were purchased at an average price of GBX 214 ($2.59) per share, with a total value of £42,800 ($51,715.80). Also, insider Lily Liu bought 2,000 shares of the company's stock in a transaction on Monday, August 8th. The shares were purchased at an average cost of GBX 193 ($2.33) per share, for a total transaction of £3,860 ($4,664.09). In the last quarter, insiders have acquired 92,000 shares of company stock valued at $17,896,000. Synthomer Stock Up 0.8 %

Shares of LON:SYNT opened at GBX 205.80 ($2.49) on Friday. The company has a fifty day moving average of GBX 229.88 and a 200-day moving average of GBX 277.80. The company has a market capitalization of £961.78 million and a PE ratio of 1,083.16. The company has a debt-to-equity ratio of 114.88, a quick ratio of 0.97 and a current ratio of 1.60. Synthomer has a 52-week low of GBX 182.30 ($2.20) and a 52-week high of GBX 551 ($6.66). Synthomer Cuts Dividend

The firm also recently declared a dividend, which will be paid on Friday, November 4th. Investors of record on Thursday, October 6th will be given a GBX 4 ($0.05) dividend. The ex-dividend date is Thursday, October 6th. This represents a yield of 1.7%. Synthomer's payout ratio is 157.89%. About Synthomer (Get Rating)

Synthomer plc operates as a specialty chemicals company. It operates through four segments: Performance Elastomers, Functional Solutions, Industrial Specialities, and Acrylate Monomers. The company offers pressure sensitive adhesives, acrylic polymers, acrylic dispersions, saturants, release coatings, and other adhesives; water-based carboxylated styrene butadiene rubber, redispersible powder, flooring adhesive, and additives for construction applications; and impregnation binders, styrene butadiene copolymers, dispersions, polymer binders, and butadiene-based binders for textiles applications.Featured StoriesInstitutional Support For TJX Companies May Cap GainsIf You Hate Speed Cameras, Then You’ll Like Verra Mobility Stock Is Sanofi A Buy, Despite Recent Stumbles? Starbucks Stock, Is Brand Loyalty Enough Reason to BuyBJ’s Wholesale Club Pops, Will Costco Be Next?

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Before you consider Synthomer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synthomer wasn't on the list.

While Synthomer currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:

David McNatt discusses ESG investing and offers ways to avoid pitfalls and to understand exactly what kinds of companies you are buying.

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved. 326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257 MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.